Updated
Updated · Business Insider · Jul 22
Neuralink Hits $42 Billion in Secondary Trades as Bidders Test Nearly $60 Billion
Updated
Updated · Business Insider · Jul 22

Neuralink Hits $42 Billion in Secondary Trades as Bidders Test Nearly $60 Billion

3 articles · Updated · Business Insider · Jul 22

Summary

  • $42 billion valuations have emerged in recent Neuralink secondary-market trades, nearly five times the brain-chip startup's $9 billion valuation from its last funding round.
  • Caplight data showed recent transactions ranging from $29 billion to $42 billion, with some buyers trying to acquire shares at almost $60 billion as demand for Elon Musk-linked private companies intensifies.
  • That demand has accelerated after SpaceX's IPO, which lifted Musk's wealth and reinforced investor expectations that stakes across his companies can gain value through ties to his broader AI and robotics empire.
  • Neuralink remains early-stage despite the surge: its implants have been used in 21 trial patients so far, and the company has not disclosed a new funding round or an official current valuation.

Insights

Is Neuralink’s $42B valuation based on medical reality or the 'Musk effect'?
As investors pour billions into brain implants, how will we protect our very thoughts from being hacked or sold?
With brain chips now in 21 patients, what is the biggest barrier to this technology becoming a common cure?